Abstract
The earlier chapters of this volume have attempted to identify potential new target molecules that may represent useful cancer markers and have provided information regarding their biological function as well as the potential or actual clinical utilization to the extent that such information is known. These candidate tumor markers reflect alterations in antigenic composition and alterations in gene expression and gene structure. A listing of some of the antigenic and genetic alterations judged to be most promising is presented in Table 1. Which of these will ultimately be incorporated into clinical practice is unknown. Selection of more effective tumor markers will lead to improvement in the quality of patient care, whereas selection of ineffective markers will inflate health care costs without perceived benefit. The latter will serve to cast added doubt on the usefulness for supporting development of new markers in the future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aziz, K. J. and P. E. Maxim (1993), Clin. Chem. 39, 2439–2443.
Bloch, D. A. and H. C. Kraemer (1989), Biometrics 45, 269–287.
Boyko, E. J. (1994), Med. Decis. Making 14, 175–179.
Burk, M. D. (1990), Am. J. Clin. Pathol. 94, 663, 664.
Cohen, J. (1960), Educ. Psychol. Meas. 20, 37–46.
Committee for Evaluating Medical Technologies, Institute of Medicine, National Academy of Sciences (1985), National Academy Press, Washington, DC, pp. 70–175.
Connell, F. A. and T. D. Koepsell (1985), Am. J. Epidemiol. 121, 744–753.
Cossman, J., B. Zehnbauer, C. T. Garrett, L. J. Smith, M. Williams, E. S. Jaffe, L. O. Hanson, and J. Love (1991), Am. J. Clin. Pathol. 95, 347–354.
Council on Scientific Affairs and the Council on Medical Service, American Medical Association (1992), Arch. Intern. Med. 152, 46–50.
Diamond, G. A., M. Hirsch, J. S. Forrester, H. M. Staniloff, R. Vas, S. W. Halpern, and H. J. C. Swan (1981), Circulation 63, 915–921.
Diamond, G. A. and T. A. Denton (1993), Ann. Intern. Med. 118, 455–464.
Diamond, G. A., F. A. Denton, and J. M. Matloff (1993), J. Am. College Cardiol. 22, 343–352.
Eddy, D. M., V. Hasselbald, and R. Shachter (1990), Int. J. Technol. Assess. in Health Care 6, 31–55.
Fleiss, J. L. (1981), Statistical Methods for Rates and Proportions, 2nd ed. John Wiley, New York.
Galen, R. S. and S. R. Gambino (1975), Beyond Normality: the Predictive Value and Efficiency of Medical Diagnoses. John Wiley, New York.
Garrett, C. T., A. Ferreira-Centeno, and S. Nasim (1993), Clin. Chim. Acta 217, 85–103.
Irwig, L., A. N. A. Tosteson, C. Gatsonis, J. Lau, G. Colditz, T. C. Chalmers, and F. Mosteller (1994), Ann. Intern. Med. 120, 667–676.
Johnson, H. A. (1970), Science 168, 1545–1550.
Johnson, H. A. (1989), Ann. Clin. Lab. Sci. 19, 323–331.
Johnson, H. A. (1993), Ann. Clin. Lab. Sci. 23, 159–164.
Kraemer, H. C. (1987), Psychoneuroendocrinology 12, 411–427.
Kraemer, H. C. (1988), Am. Statistician 42, 37–49.
Kraemer, H. C. (1992), Evaluating Medical Tests-Objective and Quantitative Guidelines. Sage, Newbury Park, CA.
Laird, N. M. and F. Mosteller (1990), Int. J. Technol. Assess. in Health Care 6, 5–30.
Logue, L. J. (1993), Clin. Chem. 39, 2435–2438.
Metz, C. E., D. J. Goodenough, and K. Rossmann (1973), Radiology 109, 297–303.
Midgette, A. S., T. A. Stukel, and B. Littenberg (1993), Med. Decis. Making 13, 253–257.
Moses, L. E., D. Shapiro, and B. Littenberg (1993), Statistics in Med. 12, 1293–1316.
Simel, D. L., G. P. Samsa, and D. B. Matchar (1991), J. Clin. Epidemiol. 44, 763–770.
Somoza, E. (1994), Med. Decis. Making 14, 157–168.
Somoza, E. and D. Mossman (1992), Med. Decis. Making 12, 179–188.
Somoza, E., L. Soutullo-Esperon, and D. Mossman (1989), Int. J. Biomed. Comput. 24, 153–189.
Sox, H., S. Stern, D. Owens, and H. L. Abrams (1989), Assessment of Diagnostic Technology in Health Care-Rationale, Methods, Problems, and Directions. National Academic Press, Washington, DC.
Steinberg, E. P. and S. Graziano (1990), QRB Qual. Rev. Bull. 16, 218–222.
Werner, M. (1993), Clin. Chem. 39, 1361–1368.
Werner, M., M. S. Ballo, and J. V. Gallagher (1993), Clin. Chim. Acta 217, 39–55.
Werner, M., S. H. Brooks, and R. Wette (1973), Human Pathol. 4, 17–30.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Garrett, C.T., Sell, S. (1995). Summary and Perspective. In: Garrett, C.T., Sell, S. (eds) Cellular Cancer Markers. Contemporary Biomedicine, vol 12. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2381-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2381-6_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-000-7
Online ISBN: 978-1-4757-2381-6
eBook Packages: Springer Book Archive